TPST Earnings Tempest Therapeutics, Inc.
Reported diluted EPS by fiscal period (SEC EDGAR). Chart & overview →
1–20 of 20
| Q1 2026 | 2026-03-31 | -2.53 | 2026-05-14 | 10-Q |
| FY 2025 | 2025-12-31 | -6.33 | 2026-03-30 | 10-K |
| Q3 2025 | 2025-09-30 | -5.71 | 2025-11-05 | 10-Q |
| Q2 2025 | 2025-06-30 | -5.17 | 2025-08-11 | 10-Q |
| Q1 2026 | 2025-03-31 | -3.16 | 2026-05-14 | 10-Q |
| FY 2025 | 2024-12-31 | -19.50 | 2026-03-30 | 10-K |
| Q3 2025 | 2024-09-30 | -15.48 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | -10.15 | 2025-08-11 | 10-Q |
| Q1 2025 | 2024-03-31 | -4.62 | 2025-05-13 | 10-Q |
| FY 2024 | 2023-12-31 | -1.91 | 2025-03-27 | 10-K |
| Q3 2024 | 2023-09-30 | -1.57 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -1.09 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.55 | 2024-05-09 | 10-Q |
| FY 2023 | 2022-12-31 | -3.09 | 2024-03-19 | 10-K |
| Q3 2023 | 2022-09-30 | -2.46 | 2023-11-08 | 10-Q |
| Q2 2023 | 2022-06-30 | -1.88 | 2023-08-10 | 10-Q |
| Q1 2023 | 2022-03-31 | -1.18 | 2023-05-10 | 10-Q |
| FY 2022 | 2021-12-31 | -7.47 | 2023-03-22 | 10-K |
| Q3 2022 | 2021-09-30 | -7.49 | 2022-11-08 | 10-Q |
| Q2 2022 | 2021-06-30 | -17.30 | 2022-08-15 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Informational only — not financial advice.